ID: ALA4176504

Max Phase: Preclinical

Molecular Formula: C21H19NO4

Molecular Weight: 349.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(C(=O)N(C)c2cccc(Oc3ccc(O)cc3)c2)c1

Standard InChI:  InChI=1S/C21H19NO4/c1-22(21(24)15-5-3-7-19(13-15)25-2)16-6-4-8-20(14-16)26-18-11-9-17(23)10-12-18/h3-14,23H,1-2H3

Standard InChI Key:  QVCDUYLTTDFFQS-UHFFFAOYSA-N

Associated Targets(non-human)

Androgen Receptor 399 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 349.39Molecular Weight (Monoisotopic): 349.1314AlogP: 4.47#Rotatable Bonds: 5
Polar Surface Area: 59.00Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.69CX Basic pKa: CX LogP: 3.97CX LogD: 3.97
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.74Np Likeness Score: -1.00

References

1. Kazui Y, Fujii S, Yamada A, Ishigami-Yuasa M, Kagechika H, Tanatani A..  (2018)  Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.,  26  (18): [PMID:30228001] [10.1016/j.bmc.2018.09.008]

Source